Cargando…

Fenoldopam Mesylate Enhances the Survival of Mesenchymal Stem Cells Under Oxidative Stress and Increases the Therapeutic Function in Acute Kidney Injury

Mesenchymal stem cells (MSCs) have gained interest as an alternative therapeutic option for renal diseases, including acute kidney injury (AKI). However, their use is often limited owing to low survival rates in vivo. Fenoldopam mesylate (FD) is a selective dopamine D1 receptor agonist with antioxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Seo Yeon, Cho, Hye Jin, Kim, Tae Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830573/ https://www.ncbi.nlm.nih.gov/pubmed/36594258 http://dx.doi.org/10.1177/09636897221147920

Ejemplares similares

Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
por: Noce, Annalisa, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients
por: Hammer, Gregory B, et al.
Publicado: (2008)

Renal protection in the ICU: role of fenoldopam
por: Bertini, P, et al.
Publicado: (2008)

Effects of fenoldopam on kidney function parameters and its therapeutic efficacy in the management of acute kidney injury in dogs with heatstroke
por: Segev, Gilad, et al.
Publicado: (2018)

Fenoldopam Increases Urine Output in Oliguric Critically Ill Surgical Patients
por: Cagliani, Joaquin A, et al.
Publicado: (2021)

Periferic intravenous infusion of fenoldopam through an elastomeric pump
por: Quaranta, T, et al.
Publicado: (2009)

Fenoldopam to prevent acute kidney injury after major surgery—a systematic review and meta-analysis
por: Gillies, Michael A., et al.
Publicado: (2015)

Fenoldopam use in a burn intensive care unit: a retrospective study
por: Simmons, John W, et al.
Publicado: (2010)

Detection of fenoldopam-induced arteritis in rats using ex vivo / in vivo MRI
por: Fujii, Yuta, et al.
Publicado: (2022)

A novel use for novel acute kidney injury biomarkers: fenoldopam's effect on neutrophil gelatinase-associated lipocalin and cystatin C
por: Goldstein, Stuart L
Publicado: (2011)

Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study
por: Landoni, G, et al.
Publicado: (2010)

Effect of Fenoldopam Continuous Infusion on Glomerular Filtration Rate and Fractional Excretion of Sodium in Healthy Dogs
por: Kelly, K.L., et al.
Publicado: (2016)

High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery
por: Ricci, Zaccaria, et al.
Publicado: (2011)

Beneficial Impacts of Fenoldopam on Patients With or at Risk for Acute Renal Failure and Undergoing Surgery: A Meta-Analysis of Randomized Clinical Trials
por: Kondabolu, Sai Kiran, et al.
Publicado: (2023)

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
por: Cho, Ah Young, et al.
Publicado: (2011)

Exacerbation of Psoriasis after Imatinib Mesylate Treatment
por: Shim, Joon Ho, et al.
Publicado: (2016)

Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury
por: Guo, Wenli, et al.
Publicado: (2022)

Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
por: Kim, Pyung-Hwan, et al.
Publicado: (2015)

Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials
por: Seo, Jung Hwa, et al.
Publicado: (2012)

Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis
por: Kim, Gi Beom, et al.
Publicado: (2021)

Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
por: Lee, Jae-Hyung, et al.
Publicado: (2013)

Periorbital edema secondary to imatinib mesylate
por: McClelland, Collin M, et al.
Publicado: (2010)

Cutaneous adverse effects of imatinib mesylate
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2015)

Therapeutic efficacy of an injectable formulation of purinostat mesylate in SU-DHL-6 tumour model
por: Zhu, Zejiang, et al.
Publicado: (2022)

The therapeutic effect of bromocriptine as mesylate and estradiol valerate on serum and blood biochemistry of common quails
por: ul- Abideen, Zain, et al.
Publicado: (2021)

New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate
por: Cui, Jihong, et al.
Publicado: (2016)

Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis
por: Go, Seong Woo, et al.
Publicado: (2013)

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
por: Wang, Jiali, et al.
Publicado: (2022)

Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
por: Erguven, Mine, et al.
Publicado: (2011)

Therapeutic potential of stem cell-derived extracellular vesicles in osteoarthritis: preclinical study findings
por: Kim, Ki Hoon, et al.
Publicado: (2020)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

Determination of Doxazosin Mesylate in Tablets by RP-HPLC
por: Dhanya, B., et al.
Publicado: (2011)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Easy and direct conversion of tosylates and mesylates into nitroalkanes
por: Palmieri, Alessandro, et al.
Publicado: (2013)

Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
por: Song, Hyo Sang, et al.
Publicado: (2014)

Imatinib mesylate resistance and mutations: An Indian experience
por: Srivastava, Shweta, et al.
Publicado: (2013)

Lichenoid drug eruption due to imatinib mesylate
por: Bhatia, Anuradha, et al.
Publicado: (2015)

The teratogenic effects of imatinib mesylate on rat fetuses
por: El Gendy, M.M., et al.
Publicado: (2015)

Synthesis, Characterization, and Pharmacodynamics Study of Enrofloxacin Mesylate
por: Pei, Lin-lin, et al.
Publicado: (2020)

Salvia miltiorrhiza enhances the survival of mesenchymal stem cells under ischemic conditions
por: Kim, Ran, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9baalrgo5bvkdjk8js718v7tcm